USD 34.66
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 2.72 Billion EUR | -57.2% |
2022 | 3.09 Billion EUR | -6.73% |
2021 | 6.94 Billion EUR | -2.97% |
2020 | 7.19 Billion EUR | -0.75% |
2019 | 7.24 Billion EUR | 15.88% |
2018 | 6.22 Billion EUR | 0.06% |
2017 | 6.23 Billion EUR | 11.2% |
2016 | 5.61 Billion EUR | 6.69% |
2015 | 5.24 Billion EUR | 25.51% |
2014 | 4.17 Billion EUR | 7.6% |
2013 | 3.83 Billion EUR | -0.08% |
2012 | 3.88 Billion EUR | 21.74% |
2011 | 3.19 Billion EUR | 5.69% |
2010 | 3.02 Billion EUR | 15.88% |
2009 | 2.6 Billion EUR | 10.79% |
2008 | 2.35 Billion EUR | -50.46% |
2007 | 2.05 Billion EUR | 7.34% |
2006 | 4.42 Billion EUR | 27.89% |
2005 | 3.46 Billion EUR | 13.67% |
2004 | 3.04 Billion EUR | 181.33% |
2003 | 1.08 Billion EUR | -5.99% |
2002 | 1.15 Billion EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 850 Million EUR | 5.72% |
2024 Q2 | 587 Million EUR | -33.29% |
2023 Q3 | 346 Million EUR | -72.25% |
2023 Q1 | 1.49 Billion EUR | -12.29% |
2023 FY | - EUR | -57.2% |
2023 Q2 | 1.24 Billion EUR | -16.36% |
2023 Q4 | 797 Million EUR | 130.35% |
2022 Q1 | 1.59 Billion EUR | -19.93% |
2022 Q3 | 1.65 Billion EUR | 8.51% |
2022 Q4 | 1.7 Billion EUR | 2.53% |
2022 FY | - EUR | -6.73% |
2022 Q2 | 1.52 Billion EUR | -4.2% |
2021 FY | - EUR | -2.97% |
2021 Q1 | 1.62 Billion EUR | -17.78% |
2021 Q2 | 1.66 Billion EUR | 2.09% |
2021 Q3 | 1.66 Billion EUR | 0.3% |
2021 Q4 | 1.99 Billion EUR | 19.5% |
2020 Q4 | 1.98 Billion EUR | 14.92% |
2020 Q3 | 1.72 Billion EUR | -1.94% |
2020 Q1 | 1.7 Billion EUR | -18.09% |
2020 FY | - EUR | -0.75% |
2020 Q2 | 1.75 Billion EUR | 2.93% |
2019 Q1 | 1.68 Billion EUR | -14.55% |
2019 FY | - EUR | 15.88% |
2019 Q2 | 1.69 Billion EUR | 0.36% |
2019 Q3 | 1.75 Billion EUR | 3.66% |
2019 Q4 | 2.08 Billion EUR | 18.81% |
2018 FY | - EUR | 0.06% |
2018 Q4 | 1.97 Billion EUR | 42.76% |
2018 Q3 | 1.38 Billion EUR | -6.24% |
2018 Q2 | 1.47 Billion EUR | 6.43% |
2018 Q1 | 1.38 Billion EUR | -17.02% |
2017 Q4 | 1.66 Billion EUR | 13.85% |
2017 FY | - EUR | 11.2% |
2017 Q2 | 1.52 Billion EUR | -2.05% |
2017 Q1 | 1.56 Billion EUR | -5.28% |
2017 Q3 | 1.46 Billion EUR | -4.06% |
2016 Q1 | 1.23 Billion EUR | -22.64% |
2016 FY | - EUR | 6.69% |
2016 Q4 | 1.64 Billion EUR | 19.96% |
2016 Q3 | 1.37 Billion EUR | 2.54% |
2016 Q2 | 1.33 Billion EUR | 8.25% |
2015 Q4 | 1.59 Billion EUR | 23.38% |
2015 FY | - EUR | 25.51% |
2015 Q2 | 1.21 Billion EUR | 6.68% |
2015 Q1 | 1.13 Billion EUR | -7.94% |
2015 Q3 | 1.29 Billion EUR | 6.84% |
2014 Q2 | 1.01 Billion EUR | 13.96% |
2014 Q3 | 1.04 Billion EUR | 3.16% |
2014 Q4 | 1.23 Billion EUR | 18.3% |
2014 FY | - EUR | 7.6% |
2014 Q1 | 888 Million EUR | -18.83% |
2013 Q1 | 891 Million EUR | -19.58% |
2013 Q3 | 957 Million EUR | 1.59% |
2013 Q4 | 1.09 Billion EUR | 14.32% |
2013 FY | - EUR | -0.08% |
2013 Q2 | 942 Million EUR | 5.72% |
2012 Q2 | 961 Million EUR | 14.68% |
2012 Q1 | 838 Million EUR | -1.3% |
2012 FY | - EUR | 21.74% |
2012 Q4 | 1.1 Billion EUR | 13.18% |
2012 Q3 | 979 Million EUR | 1.87% |
2011 Q4 | 849 Million EUR | 3.79% |
2011 Q1 | 675 Million EUR | -22.86% |
2011 FY | - EUR | 5.69% |
2011 Q2 | 789 Million EUR | 16.89% |
2011 Q3 | 818 Million EUR | 3.68% |
2010 Q3 | 814 Million EUR | 11.35% |
2010 FY | - EUR | 15.88% |
2010 Q1 | 598 Million EUR | -17.63% |
2010 Q4 | 875 Million EUR | 7.49% |
2010 Q2 | 731 Million EUR | 22.24% |
2009 Q4 | 726 Million EUR | 25.61% |
2009 Q3 | 578 Million EUR | -5.71% |
2009 Q2 | 613 Million EUR | -11.16% |
2009 Q1 | 690 Million EUR | 0.0% |
2009 FY | - EUR | 10.79% |
2008 FY | - EUR | -50.46% |
2007 FY | - EUR | 7.34% |
2006 FY | - EUR | 27.89% |
2005 FY | - EUR | 13.67% |
2004 FY | - EUR | 181.33% |
2003 FY | - EUR | -5.99% |
2002 FY | - EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
The Amacore Group, Inc. | -10.98 Million USD | 24928.145% |
Arem Pacific Corporation | 36.71 Thousand USD | -7427381.956% |
Assisted 4 Living, Inc. | -112.91 Thousand USD | 2415276.555% |
BioCorRx Inc. | -2.68 Million USD | 101705.039% |
Bionik Laboratories Corp. | -4.77 Million USD | 57201.433% |
Banyan Corp. | 583.94 Thousand USD | -466898.435% |
Clearday, Inc. | -7.53 Million USD | 36284.462% |
Dental Patient Care America, Inc. | 12.87 Thousand USD | -21183773.223% |
Quantum Medical Transport, Inc. | - USD | -Infinity% |
Empower Clinics Inc. | -1.08 Million USD | 250679.125% |
First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 123505.447% |
Selectis Health, Inc. | -7.29 Million USD | 37485.771% |
Ethema Health Corporation | 2.07 Million USD | -131501.045% |
HealthLynked Corp. | -2.75 Million USD | 99252.639% |
HQDA Elderly Life Network Corp. | - USD | -Infinity% |
Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 102835.585% |
JRSIS Health Care Corporation | 28.84 Thousand USD | -9453550.419% |
Comjoyful International Company | 167.89 Thousand USD | -1624129.429% |
Medical Facilities Corporation | 77.94 Million USD | -3398.621% |
MedSmart Group Inc. | 47.8 Thousand USD | -5703846.956% |
North America Frac Sand, Inc. | -623.33 Thousand USD | 437588.971% |
Nova Leap Health Corp. | 994.46 Thousand USD | -274117.795% |
Nexteligent Holdings, Inc. | -201.73 Thousand USD | 1351906.871% |
PAO Group, Inc. | 292.96 Thousand USD | -930734.269% |
Primemd Inc. | 3.42 Million USD | -79475.318% |
Raffles Medical Group Ltd | 100.7 Million USD | -2608.039% |
Ryman Healthcare Limited | -54.51 Million USD | 5102.072% |
Stem Cell Authority, Ltd. | -4233.00 USD | 64422495.464% |
SETO Holdings, Inc. | - USD | -Infinity% |
Optima Medical Innovations Corp. | -2.89 Million USD | 94321.366% |
Mycotopia Therapies, Inc. | -555.5 Thousand USD | 491002.905% |
U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | 5565406.122% |
Veltex Corporation | -938.45 Thousand USD | 290683.372% |
World Financial Holding Group | -28.43 Thousand USD | 9592080.302% |
Xcelerate Inc. | -2.53 Million USD | 107532.247% |